載入...
Minimal manifestation status and prednisone withdrawal in the MGTX trial
OBJECTIVE: To examine whether sustained minimal manifestation status (MMS) with complete withdrawal of prednisone is better achieved in thymectomized patients with myasthenia gravis (MG). METHODS: This study is a post hoc analysis of data from a randomized trial of thymectomy in MG (Thymectomy Trial...
Na minha lista:
| 發表在: | Neurology |
|---|---|
| Main Authors: | , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , |
| 格式: | Artigo |
| 語言: | Inglês |
| 出版: |
Lippincott Williams & Wilkins
2020
|
| 主題: | |
| 在線閱讀: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7455358/ https://ncbi.nlm.nih.gov/pubmed/32611638 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1212/WNL.0000000000010031 |
| 標簽: |
添加標簽
沒有標簽, 成為第一個標記此記錄!
|